[Medical management of patients with atypical degenerative parkinsonian syndromes].
Atypical degenerative parkinsonian syndromes (progressive supranuclar palsy, multiple system atrophy, corticobasal degeneration, Lewy body dementia) are an important differential diagnosis to idiopathic Parkinson's disease. However, because these disorders are characterized by the degeneration of multiple neuronal populations, treatment approaches are much less specific than in Parkinson's disease, where dopamimetic drugs represent the mainstay of therapy. Thus, and because the progression of these disorders is usually more aggressive than Parkinson's disease, many physicians face a form of therapeutic resignation when confronted with patients suffering from atypical degenerative parkinsonian syndromes. However, in the present article, we wish to show that a symptom-by-symptom approach can substantially relieve the patients and their caregivers by providing an overview of pharmacologic and non-pharmacologic treatment options.
Chastan
N
N
Centre d'Investigation Clinique et INSERM U 679, Hôpital de la Salpêtrière, et Université Pierre et Marie Curie, Faculté de Médecine, Paris. hartmann@ccr.jussieu.fr
Hartmann
A
A
D000978:Antiparkinson Agents / Q000627:therapeutic use*; D003248:Constipation / Q000209:etiology; D003680:Deglutition Disorders / Q000209:etiology; D003704:Dementia / Q000209:etiology; D003866:Depressive Disorder / Q000209:etiology; D004421:Dystonia / Q000209:etiology; D006801:Humans; D007024:Hypotension, Orthostatic; D019636:Neurodegenerative Diseases / Q000150:complications / Q000188:drug therapy* / Q000503:physiopathology; D020734:Parkinsonian Disorders / Q000150:complications / Q000188:drug therapy* / Q000503:physiopathology; D011618:Psychotic Disorders / Q000209:etiology; D012735:Sexual Dysfunction, Physiological / Q000209:etiology; D012798:Sialorrhea / Q000209:etiology; D014570:Urologic Diseases / Q000209:etiology
D000978:Antiparkinson Agents